Valuation: Codexis, Inc.

Market Cap 145M 126M 119M 108M 202M 13.87B 203M 1.43B 550M 7.05B 543M 531M 22.69B P/E 2026 *
-3.55x
P/E 2027 * -4.62x
Enterprise Value 145M 126M 119M 108M 202M 13.87B 203M 1.43B 550M 7.05B 543M 531M 22.69B EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.63x
Free-Float
92.88%
Yield 2026 *
-
Yield 2027 * -
1 day+2.65%
1 week-7.85%
Current month-20.59%
1 month-10.00%
3 months-47.47%
6 months-8.16%
Current year-17.18%
1 week 1.27
Extreme 1.27
1.5
1 month 1.27
Extreme 1.27
1.76
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
2.98
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 59 07/11/2025
Director of Finance/CFO 59 30/09/2024
Chief Tech/Sci/R&D Officer 56 05/05/2020
Director TitleAgeSince
Director/Board Member 66 01/03/2016
Director/Board Member 59 07/11/2025
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
23/02/26 Free

Chief Financial Officer

316,100 0.3500%
23/02/26 Sell

Chief Technology Officer

321,962 0.3565%
23/02/26 Free

Chief Executive Officer

993,000 1.0994%
Change 5-day change 1-year change 3-year change Capi.($)
+2.65%-7.85%-45.78%-25.41% 145M
+0.11%+2.71%+0.33%+28.59% 46.18B
-1.09%+1.75%+40.04%+27.23% 44.35B
-3.78%-7.20%+318.18%+511.38% 42.21B
-1.03%+1.01%+2.07%+67.54% 40.19B
-0.50%-0.77%+11.86%+40.41% 29.83B
-0.66%+4.12%+21.87%+123.99% 17.17B
-0.22%-9.56% - - 15.7B
-0.57%+8.12%+22.15%+38.93% 15.32B
-2.90%-2.76%-8.25%-37.41% 13.09B
Average -0.81%+0.67%+40.27%+86.14% 26.42B
Weighted average by Cap. -1.23%+1.63%+65.43%+121.80%

Financials

2026 *2027 *
Net sales 74.09M 64.6M 61M 55.39M 104M 7.11B 104M 731M 282M 3.61B 278M 272M 11.63B 88.44M 77.12M 72.82M 66.12M 124M 8.49B 124M 872M 337M 4.31B 332M 325M 13.88B
Net income -36.35M -31.7M -29.93M -27.18M -50.92M -3.49B -51.14M -359M -138M -1.77B -137M -134M -5.71B -28.54M -24.89M -23.5M -21.34M -39.98M -2.74B -40.15M -282M -109M -1.39B -107M -105M -4.48B
Net Debt - -
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
18/09/26 $1.355 +2.65% 351,140
17/09/26 $1.320 -1.49% 1,181,438
16/09/26 $1.340 -4.29% 954,278
15/09/26 $1.400 -5.41% 608,727
14/09/26 $1.480 +1.02% 477,570
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.320USD
Average target price
6.333USD
Spread / Average Target
+379.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CDXS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!